Skip to content

LLY

ELI LILLY & Co

NYSE · Healthcare · Drug Manufacturers - General · US

$1,414.27
+0.35%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue86.5B65.2B45.0B34.1B28.5B
Cost of Revenue14.1B11.1B8.4B7.1B6.6B
Gross Profit72.3B54.1B36.6B27.0B21.9B
Operating Expenses
R&D Expense15.4B13.3B11.0B9.3B7.2B
SG&A Expense12.6B11.1B8.6B6.9B6.1B
General & Admin Expense3.1B—8.6B6.9B6.1B
Selling & Marketing Expense——200.0K——
Other Expenses4.5B————
Total Operating Expenses32.5B24.4B19.6B16.3B13.3B
Cost and Expenses46.6B35.5B28.0B23.3B19.9B
Operating Income (EBIT)39.8B29.7B17.0B10.8B8.7B
Non-Operating
Interest Income—153.3M175.2M173.6M62.8M
Interest Expense1.2B795.3M780.6M485.9M331.6M
Net Interest Income(1.2B)(642.0M)(605.4M)(312.3M)(268.8M)
Other Non-Op Income/Expense(5.1B)(4.0B)(4.4B)(4.2B)(1.8B)
Non-Operating Income (excl Interest)(2.7B)——3.7B1.5B
EBT (Pre-Tax Income)34.8B25.7B12.7B6.6B6.8B
Income Tax Expense7.2B5.1B2.1B1.3B561.6M
Bottom Line
Net Income27.6B20.6B10.6B5.2B6.2B
Earnings from Cont. Ops27.6B20.6B10.6B5.2B6.2B
Earnings from Discont. Ops—————
Bottom Line Net Income27.6B20.6B10.6B5.2B6.2B
Per Share
Basic EPS$30.89$23.07$11.76$5.83$6.57
Diluted EPS$30.81$22.95$11.71$5.80$6.57
Revenue Per Share$96.94$72.58$50.01$37.94$30.04
Shares
Basic Shares Outstanding891.9M898.0M900.6M899.4M950.2M
Diluted Shares Outstanding893.4M898.0M904.1M903.3M950.2M
Profitability Metrics
EBITDA44.8B31.7B18.8B8.6B8.7B
D&A2.2B2.0B1.8B1.5B1.5B
EBIT42.6B29.7B17.0B7.0B7.1B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026